BioNexus Gene Lab Corp Common stock (BGLC) had the highest return between 2018 and 2022 by a US stock, returning 2,780,387.8%.

ASSET	YEARS	% RETURN
BioNexus Gene Lab Corp Common stock (BGLC)	2018-2022	2,780,387.8%
Graphex (GRFX)	2018-2022	799,900%
Avalon GloboCare (ALBT)	2018-2022	487,400%
Immatics (IMTX)	2018-2022	174,100%
AppTech Payments Corp Warrant (APCXW)	2018-2022	140,200%
Faraday Future Intelligent Electric (FFIE)	2018-2022	28,779.58%
FitLife Brands, Inc Common Stock (FTLF)	2018-2022	25,379.23%
Alarum Technologies (ALAR)	2018-2022	19,412.2%
Kaival Brands Innovations (KAVL)	2018-2022	14,858.33%
Enphase Energy (ENPH)	2018-2022	10,986.19%
Applied Digital (APLD)	2018-2022	5,011.11%
Xpel (XPEL)	2018-2022	4,100%
Zivo Bioscience (ZIVO)	2018-2022	2,817.15%
Nocera (NCRA)	2018-2022	2,465.13%
HighPeak Energy (HPKEW)	2018-2022	2,236.36%
Graf Industrial Corp Warrants (each warrant exercisable for one-half of one share of common stock each at an exercise price of $1150 per share) (GRAF.WT)	2018-2022	2,208.78%
Teekay Tankers (TNK)	2018-2022	2,143.57%
374Water Inc Common Stock (SCWO)	2018-2022	2,100%
Celsius (CELH)	2018-2022	1,855.68%
Empire Petroleum (EP)	2018-2022	1,821.97%
Tandem Diabetes Care (TNDM)	2018-2022	1,812.77%
Sigma Lithium Resources (SGML)	2018-2022	1,802.9%
Golden Matrix (GMGI)	2018-2022	1,593.33%
Accolade (ACCD)	2018-2022	1,316.36%
Xenon Pharmaceuticals (XENE)	2018-2022	1,308.21%